Friday, September 03, 2021 9:54:32 AM
42 U.S.C. 282(j)(3)(C) - Requirements for the Secretary of the NIH, for including data in the data bank for approved drugs and devices.
42 U.S.C. 282(j)(3)(I) - Requirements for the Secretary of the NIH, for determining "the best method for including in the registry and results data bank appropriate results information on serious adverse and frequent adverse events for applicable clinical trials described in subparagraph (C) in a manner and form that is useful and not misleading to patients, physicians, and scientists."
§ 11.42(a) applies to "Applicable clinical trials for which the studied product is approved, licensed, or cleared by FDA."
§ 11.42(b) applies to "Applicable clinical trials for which the studied product is not approved, licensed, or cleared by FDA. Unless a waiver of the requirement to submit clinical trial results information is granted in accordance with §?11.54"
§ 11.48 specifies what information is to be reported by ACTs in § 11.42.
§ 11.54 sets out the procedure for requesting a waiver of the reporting requirements. (Good for up to 2 years I think.)
So what you want to point to is § 11.42(b).
However, none of this gives individuals standing to enforce these requirements nor to force a government agency to prosecute a suspected offender. Once more, see e.g. Inmates of Attica Correctional Facility v Rockefeller, 477 F.2d 375 (1973).
What HappyLibrarian suggests is that like seeking some TRO or injunctive relief, one can walk into Federal court, make a statement that somehow requires the judge to hold a quick hearing and then the Court will issue a Writ requiring the FDA to enforce a law on a specific company, that the FDA will then immediately order the company to release TLD and the company will then, a week after the motion was filed, release TLD. What I am telling you is that it WILL. NEVER. HAPPEN. You have no standing. You can point to no harm. The FDA has no obligation to prosecute specific companies that you wish to hold accountable, especially when less than half of trials have results reported on time. The Judge is going to defer to the Agency absent some flagrant abuse of discretion. "Arbitrary and Capricious" is the term you will likely see.
If the Judge doesn't simply dismiss the case out of hand, it gets sent to the appropriate government agency for a response. Expect a response in 3 months or so. The response will likely request dismissal under 12(b)(5) or require an amended complaint stating the particulars. Another 4-6 months may pass before the motion to dismiss is considered and a year or so after filing your case is dismissed for lack of standing or failure to state a claim.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM